Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Paracetamol ODT - Adare Pharmaceuticals

Drug Profile

Paracetamol ODT - Adare Pharmaceuticals

Alternative Names: Acetaminophen ODT; AdvaTab Paracetamol ODT; Orally disintegrating paracetamol; Orodispersible paracetamol

Latest Information Update: 14 May 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Eurand
  • Developer Adare Pharmaceuticals; Aptalis
  • Class Acetanilides; Aminophenols; Antipyretics; Non-opioid analgesics; Small molecules
  • Mechanism of Action Prostaglandin inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Registered Fever; Pain

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 09 Mar 2015 No recent reports on development identified - Registered for Pain and Fever in Netherlands and United Kingdom (PO)
  • 09 Mar 2015 No recent reports on development identified - Preregistration for Pain and Fever in Germany, France, Italy and Spain (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top